Open randomised trial in 69 intracerebral haemorrhage survivors, stopped early for slow recruitment (target 500): starting vs avoiding antiplatelets had numerically more recurrent ICH (15% vs 3%) but fewer major ischaemic events (9% vs 20%).
RCTn = 69
Eilertsen et al. Study of Antithrombotic Treatment After Intracerebral Haemorrhage-Antiplatelets: A Randomized Trial